Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for CervoMed (CRVO) over the last 9 years, with Q3 2025 value amounting to -$434813.0.

  • CervoMed's Change in Account Payables fell 22193.95% to -$434813.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $266784.0, marking a year-over-year decrease of 5571.74%. This contributed to the annual value of $848969.0 for FY2024, which is 5021.51% up from last year.
  • CervoMed's Change in Account Payables amounted to -$434813.0 in Q3 2025, which was down 22193.95% from -$76566.0 recorded in Q2 2025.
  • Over the past 5 years, CervoMed's Change in Account Payables peaked at $429005.0 during Q4 2024, and registered a low of -$434813.0 during Q3 2025.
  • Its 3-year average for Change in Account Payables is $113810.6, with a median of $240257.0 in 2023.
  • In the last 5 years, CervoMed's Change in Account Payables surged by 45346.7% in 2024 and then crashed by 22193.95% in 2025.
  • Over the past 3 years, CervoMed's Change in Account Payables (Quarter) stood at $182494.0 in 2023, then skyrocketed by 135.08% to $429005.0 in 2024, then plummeted by 201.35% to -$434813.0 in 2025.
  • Its Change in Account Payables was -$434813.0 in Q3 2025, compared to -$76566.0 in Q2 2025 and $349158.0 in Q1 2025.